SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-002277
Filing Date
2022-01-06
Accepted
2022-01-06 20:51:15
Documents
2
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2869
2 POA DOCUMENT poa.txt EX-24 4044
  Complete submission text file 0001209191-22-002277.txt   8276
Mailing Address C/O IMPEL NEUROPHARMA, INC. 201 ELLIOTT AVE. W, ST. 260 SEATTLE WA 98119
Business Address
Allison David D. (Reporting) CIK: 0001853903 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41201 | Film No.: 22516286

Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Issuer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations